UK donor plasma could have an immediate beneficial effect on the availability of plasma-derived medicinal products in Europe
- PMID: 37395348
- DOI: 10.1111/vox.13488
UK donor plasma could have an immediate beneficial effect on the availability of plasma-derived medicinal products in Europe
References
REFERENCES
-
- Barry S. Work plan for the biologics working party (BWP) for 2023. 2023. Available from: https://www.ema.europa.eu/en/documents/work-programme/work-plan-biologic....
-
- Thomas S, Roberts B, Domanović D, Kramer K, Klochkov D, Sivasubramaniyam S, et al. Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variant Creutzfeldt-Jakob disease. Vox Sang. 2023;118:345-53.
-
- Office of the Commissioner. Executive order 13944 list of essential medicines, medical countermeasures, and critical inputs.Washington DC: FDA; 2023.
-
- Prevot J, Jolles S. Global immunoglobulin supply: steaming towards the iceberg? Curr Opin Allergy Clin Immunol. 2020;20:557-64.
-
- Oral presentations. Vox Sang. 2023;118:6-379.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical